<DOC>
	<DOCNO>NCT03029377</DOCNO>
	<brief_summary>The objective study measure sympathetic nervous system function stress responses patient clinically document self-reported chronic fatigue worsen stress , compare healthy control . Baseline norepinephrine ( NE ) level stress-induced NE level patient fulfill criterion Chronic Fatigue Syndrome ( CFS ) self-identify stress induce worsen fatigue , compare data normal individual pre post-stress .</brief_summary>
	<brief_title>Noradrenergic Stress-Related Etiologies Chronic Fatigue Syndrome</brief_title>
	<detailed_description>Symptoms Chronic Fatigue Syndrome ( CFS ) critically important study patient report symptom often profoundly debilitate impediment effective daily function well effective vocational social functioning , also contribute significantly increase risk psychiatric illness diminish quality life . Previous Phenome-Wide Association ( PheWAS ) study reveal link norepinephrine transporter ( NET ) genetic variant CFS . Based potential function variant publish literature , elevate norepinephrine ( NE ) level may underlie least cluster fatigue symptom . Some patient may experience chronic fatigue due excess circulate NE , fatigue symptom report patient population commonly exacerbate stress . This study test hypothesis subset people severely debilitate fatigue long duration ( &gt; 6 month ) worsen stress identify Vanderbilt electronic health record phenotyping study , chronic over-release hormone NE bloodstream/periphery time result overload NE . This overload NE cause compensatory deleterious effect brain nervous system , include sympathetic effect dysregulated physiologic response stress . Thus , numerous currently approve therapy target NET inhibit transporter , drug opposite mechanism action , NET activator would decrease circulate NE , may efficacy treat underlie pathophysiology chronic fatigue . Baseline NE level stress-induced NE level patient fulfill criterion CFS self-identify stress induce worsen fatigue , compare data normal individual pre post-stress . After inclusion criterion confirm , IV place blood collection , continuous electrocardiographic trace blood pressure cuff place subject 's arm finger . Subjects undergo posture study , autonomic reflex testing , Stroop stress test follow blood specimen collection . An optional blood draw DNA analysis occur patient provide lunch . Questionnaires complete study procedure patient provide lunch . Study blood collection total 28 milliliter ( mL ) : 5 mL cytokine , 20 mL catecholamine , optional 3 mL DNA .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Fatigue Syndrome , Chronic</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<criteria>Chronic Fatigue Participants : Confirmed chronic fatigue severity &gt; 50 scale 1 100 improving time Meet The Centers Disease Control Prevention ( CDC ) diagnostic criterion CFS ( selfreported persistent relapse fatigue last 6 consecutive month ) Male female subject &lt; 18 &gt; 60 year Obesity , define BMI 30 Presence medical psychiatric condition know cause fatigue ( alcohol/drug abuse , anorexia nervosa , bipolar disorder , bulimia nervosa , dementia , major depression , psychotic/delusional disorder , schizophrenia ) Presence sleep disorder/disruption know cause fatigue ( sleep apnea , narcolepsy ) Cardiovascular , pulmonary , hepatic , hematological disease history prior test define significant investigator ( include limit chronic hepatitis , chronic kidney disease , cirrhosis , emphysema , heart failure , HIV , lupus , multiple sclerosis , myasthenia gravis , rheumatoid arthritis ) History hypertension define supine rest BP &gt; 145/95 mmHg medication need antihypertensive medication Patients take medication affect autonomic function plasma catecholamine ( vasoactive drug ) , stimulant , and/or sedatives Other factor opinion investigator could potentially impact study outcome ( e.g. , underlie disease , medication , history ) * prevent participant complete protocol ( poor compliance unpredictable schedule ) Inability stand unassisted 10 minute Patients bedridden chairridden Patients colorblind Inability refusal give informed consent reason include diagnosis dementia cognitive impairment Patients pregnant breastfeed NonVUMC patient Healthy Control Participants : Participant significant report condition medication . Male female subject &lt; 18 &gt; 60 year Obesity , define BMI 30 Presence serious chronic disease , prescription medication deem investigator include hypertension define supine rest BP &gt; 145/95 mmHg medication need antihypertensive medication Other factor investigator 's opinion would prevent participant complete protocol , include poor compliance previous study unpredictable schedule Inability stand unassisted 10 minute Patients bedridden chairridden Patients colorblind Inability refusal give informed consent reason include diagnosis dementia cognitive impairment Patients pregnant breastfeed Stress Overload Score 66</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>CFS</keyword>
	<keyword>Stress</keyword>
	<keyword>Norepinephrine Transporter ( NET )</keyword>
	<keyword>Norepinephrine ( NE )</keyword>
	<keyword>Healthy Controls</keyword>
	<keyword>Fatigue</keyword>
</DOC>